The results showed that the levels of Bcl-xL and Bcl-2 decreased in glioma cells after AMT treatment, while the expression of pro-apoptotic proteins Bax and Bak was promoted (Fig. 2F). The gene discussed is BCL2L1; the disease is central nervous system cancer.